Article

Antimicrobial activity of ceftobiprole and comparator agents when tested against Gram-positive and -negative organisms collected across China (2016-2018)

2022-07-21

Abstract excerpt

<h4>Background: </h4> Ceftobiprole is a fifth-generation cephalosporin which has been reported on the antibacterial spectrum when against bacteria collected from other countries except China. This study evaluated the in vitro activity of ceftobiprole in comparison with other comparators against clinically significant isolates collected across from China. <h4>Results: </h4>: Susceptibility testing of ceftobiprole a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3d10e405-01fd-5c03-933d-de21e13ccd51
DOI: 10.21203/rs.3.rs-1852605/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antimicrobial activity of ceftobiprole and comparator agents when tested against Gram-positive and -negative organisms collected across China (2016-2018)DOI 10.21203/rs.3.rs-1852605/v1Read

In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.Semantic proximity Read

P095: The 2nd/3rd generation of cephalosprines use in antimicrobial stewardship program and contemporary carriage of E. coli and K. pneumoniae with esbls from identified or suspected infection hospitalized patientsSemantic proximity Read

In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance ProgramSemantic proximity Read

Antimicrobial Resistance Pattern among Organisms Isolated from Tertiary Care Hospital in ChennaiSemantic proximity Read

Phenotypes of antibiotic resistance in bacteria causing gastrointestinal infection isolated atSemantic proximity Read

An Overview of Cefiderocol’s Therapeutic Potential and Underlying Resistance MechanismsSemantic proximity Read

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive updateSemantic proximity Read

Developments on antibiotics for multidrug resistant bacterial Gram-negative infectionsSemantic proximity Read

Cefto-Reallife Study: Real World Data on the Use of Ceftobiprole in a Multicenter Spanish CohortSemantic proximity Read

Antimicrobial resistance trends among important clinical pathogens reported from the ARINCQ surveillance of bacterial resistance, 2012-2018: multi-center retrospective surveillance study in ChongqingSemantic proximity Read

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsSemantic proximity Read

Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016-2018.Semantic proximity Read